Skip to main content

Apyx Medical Corp

APYX
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0000719135

No open-market purchases or sales by Apyx Medical Corp insiders were filed in the last 90 days; 67 institutions reported holding it in 13F filings for Q2 2026, worth $95.6M in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding Apyx Medical Corp changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of APYX: Q1 2025 compared with Q2 2025
MeasureQ1 2025Of which not filed for Q2 2025Q2 2025Change
Holders43139−3
Shares15.8M20.0K15.8M+38.2K (+0.2%)
Value$21.6M$27.4K$35.6M+$14.0M (+64.6%)

1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (4)

Institutions that held Apyx Medical Corp at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to APYX in Q2 2025
InstitutionSharesValue% of portfolio
Advisor Group Holdings, Inc.22,200$50.0K0.00%
Fisher Asset Management, LLC14,949$33.6K0.00%
Trust Co of Toledo NA1,000$2.25K0.00%
Ameritas Advisory Services, LLC100$2250.00%

Sold out (7)

Institutions that held Apyx Medical Corp at the end of Q1 2025 and filed for Q2 2025 without it.

Institutions that sold out of APYX in Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
Rathbone Brothers plc101,334$138.8K
Wealth Enhancement Advisory Services, LLC90,750$124.3K
Strategic Advisors LLC19,430$26.6K
Citadel Advisors LLC13,566$18.6K
Tower Research Capital LLC (TRC)4,392$6.02K
Group One Trading, L.P.810$1.11K
JPMorgan Chase & Co60$82

Not filed for Q2 2025 yet (1)

Institutions that held Apyx Medical Corp at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding APYX in Q1 2025 that haven't filed for Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
CAPROCK Group, Inc.20,000$27.4K